trending Market Intelligence /marketintelligence/en/news-insights/trending/-DQrv7oFYRfPQAQ-by51rw2 content esgSubNav
In This List

Rhythm Biosciences appoints COO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Rhythm Biosciences appoints COO

Rhythm Biosciences Ltd. appointed Glenn Gilbert as COO.

Most recently, Gilbert served as head of sales and marketing, with oversight of global product commercialization, at pharmaceutical and device maker Medical Developments International Ltd.

Gilbert has previously held leadership roles at CSL Ltd.'s biotherapeutics arm, now known as Seqirus.

Australia-based Rhythm Biosciences develops and commercializes medical diagnostics technology.